Xavier Keutgen to Radiopharmaceuticals
This is a "connection" page, showing publications Xavier Keutgen has written about Radiopharmaceuticals.
Connection Strength
0.964
-
Should 68Ga-DOTATATE PET/CT be Performed Routinely in Patients with Neuroendocrine Tumors Before Surgical Resection? World J Surg. 2020 02; 44(2):604-611.
Score: 0.665
-
Prognostic Utility of Total 68Ga-DOTATATE-Avid Tumor Volume in Patients With Neuroendocrine Tumors. Gastroenterology. 2018 03; 154(4):998-1008.e1.
Score: 0.143
-
Feasibility of Radio-Guided Surgery with 68Gallium-DOTATATE in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S676-82.
Score: 0.122
-
Association between neuroendocrine tumors biomarkers and primary tumor site and disease type based on total 68Ga-DOTATATE-Avid tumor volume measurements. Eur J Endocrinol. 2017 May; 176(5):575-582.
Score: 0.034